SHERIDAN, Stephen William, Friedrich WETTERLING, Jeffrey Moore TESTANI, Barry A A BORLAUG, Marat FUDIM, Kevin DAMMAN, Alastair GRAY, Peter GAINES, Martin POLOCZEK, Stephen MADDEN, Tucker JAMES, Teresa BUXO, Robert GAUL, Louise CORCORAN, Fiachra SWEENEY and Daniel BURKHOFF. Safety and performance of a novel implantable sensor in the inferior vena cava under acute and chronic intravascular volume modulation. European Journal of heart Failure. Hoboken: Wiley, 2023, vol. 25, No 5, p. 754-763. ISSN 1388-9842. Available from: https://dx.doi.org/10.1002/ejhf.2822.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Safety and performance of a novel implantable sensor in the inferior vena cava under acute and chronic intravascular volume modulation
Authors SHERIDAN, Stephen William, Friedrich WETTERLING (guarantor), Jeffrey Moore TESTANI, Barry A A BORLAUG, Marat FUDIM, Kevin DAMMAN, Alastair GRAY, Peter GAINES, Martin POLOCZEK (203 Czech Republic, belonging to the institution), Stephen MADDEN, Tucker JAMES, Teresa BUXO, Robert GAUL, Louise CORCORAN, Fiachra SWEENEY and Daniel BURKHOFF.
Edition European Journal of heart Failure, Hoboken, Wiley, 2023, 1388-9842.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 18.200 in 2022
RIV identification code RIV/00216224:14110/23:00131029
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/ejhf.2822
UT WoS 000946155400001
Keywords in English Heart failure; Inferior vena cava; Right atrial pressure; Models; Animal; Chronic and acute response; Intravascular congestion
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 08:29.
Abstract
Aims The management of congestion is one of the key treatment targets in heart failure. Assessing congestion is, however, difficult. The purpose of this study was to investigate the safety and dynamic response of a novel, passive, inferior vena cava (IVC) sensor in a chronic ovine model.Methods and results A total of 20 sheep divided into three groups were studied in acute and chronic in vivo settings. Group I and Group II included 14 sheep in total with 12 sheep receiving the sensor and two sheep receiving a control device (IVC filter). Group III included an additional six animals for studying responses to volume challenges via infusion of blood and saline solutions. Deployment was 100% successful with all devices implanted; performing as expected with no device-related complications and signals were received at all observations. At similar volume states no significant differences in IVC area normalized to absolute area range were measured (55 +/- 17% on day 0 and 62 +/- 12% on day 120, p = 0.51). Chronically, the sensors were completely integrated with a thin, reendothelialized neointima with no loss of sensitivity to infused volume. Normalized IVC area changed significantly from 25 +/- 17% to 43 +/- 11% (p =0.007) with 300 ml infused. In contrast, right atrial pressure required 1200 ml of infused volume prior to a statistically significant change from 3.1 +/- 2.6 mmHg to 7.5 +/- 2.0 mmHg (p = 0.02).Conclusion In conclusion, IVC area can be measured remotely in real-time using a safe, accurate, wireless, and chronic implantable sensor promising to detect congestion with higher sensitivity than filling pressures.
PrintDisplayed: 20/7/2024 12:13